Click Therapeutics Announces Participation in Upcoming Investor Conferences

NEW YORK – March 2, 2023 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that company management will participate in two investor conferences this month.

• Cowen 43rd Annual Health Care Conference: March 6-8, 2023 in Boston, MA

• Barclays Global Healthcare Conference: March 14-16, 2023 in Miami, FL

Company management will participate in one-on-one meetings at both conferences. To request a meeting with the company, please reach out to the respective conference organizers.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit ClickTherapeutics.com.

Investor Contact

Daniel Busby
ir@clicktherapeutics.com

Media Contact

Jonni Mills
pr@clicktherapeutics.com